Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Sickle cell disease (SCD) is caused by a mutation (E6V) in the hemoglobin (Hb) β-chain that induces polymerization of Hb tetramers, red blood cell deformation, ischemia, anemia, and multiple organ damage. Gene therapy is a potential alternative to human leukocyte antigen (HLA)-matched allogeneic hem...

Full description

Bibliographic Details
Main Authors:	Valentina Poletti, Fabrizia Urbinati, Sabine Charrier, Guillaume Corre, Roger P. Hollis, Beatriz Campo Fernandez, Samia Martin, Michael Rothe, Axel Schambach, Donald B. Kohn, Fulvio Mavilio
Format:	Article
Language:	English
Published:	Elsevier 2018-12-01
Series:	Molecular Therapy: Methods & Clinical Development
Online Access:	http://www.sciencedirect.com/science/article/pii/S2329050118301104

Similar Items

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
by: Valentina Poletti, et al.
Published: (2018-06-01)

Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
by: Valentina Poletti, et al.
Published: (2021-08-01)

Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies
by: Mégane Brusson, et al.
Published: (2023-06-01)

The human ankyrin 1 promoter insulator sustains gene expression in a Î²-globin lentiviral vector in hematopoietic stem cells
by: Zulema Romero, et al.
Published: (2015-01-01)

Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
by: Sabine Charrier, et al.
Published: (2019-12-01)

PGE2 and Poloxamer Synperonic F108 Enhance Transduction of Human HSPCs with a β-Globin Lentiviral Vector
by: Katelyn E. Masiuk, et al.
Published: (2019-06-01)

Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy
by: Christian Brendel, et al.
Published: (2020-06-01)

Sickle cell anemia: clinical diversity and beta S-globin haplotypes
by: Sandra Regina Loggetto
Published: (2013-06-01)

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling
by: Daniel C. De Souza, et al.
Published: (2023-09-01)

Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences
by: Richard A. Morgan, et al.
Published: (2020-06-01)

Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
by: Naoya Uchida, et al.
Published: (2021-06-01)

Sickle ß-globin haplotypes among patients with sickle cell anemia in Basra, Iraq: A cross-sectional study
by: Noor Taha Yaseen, et al.
Published: (2020-01-01)

DIVERSITY OF β-GLOBIN HAPLOTYPES IN SICKLE CELL DISEASE PATIENTS FROM BRAZIL
by: ESR Sandoval, et al.
Published: (2023-10-01)

Frequency of beta S globin gene haplotypes among sickle cell patients in Nigeria
by: Abosede Adabale, et al.
Published: (2021-06-01)

The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34<sup>+</sup> Cells from Sickle Cell Disease Patients
by: Ekati Drakopoulou, et al.
Published: (2022-12-01)

Multiple origins of the sickle mutation: evidence from beta S globin gene cluster polymorphisms.
by: Wainscoat, J, et al.
Published: (1983)

Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations
by: Kaitly J. Woodard, et al.
Published: (2022-06-01)

βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells
by: Selami Demirci, et al.
Published: (2020-06-01)

Beta-S globin haplotypes in patients with sickle cell anemia: one approach to understand the diversity in Brazil
by: Jéssika Viviani Okumura, et al.
Published: (2013-01-01)

The frequency of βS-globin haplotypes in the state of Paraná, Brazil, and clinical manifestations of sickle cell anemia
by: Alexandra M. Watanabe, et al.

Fetal Haemoglobin and β-globin Gene Cluster Haplotypes among Sickle Cell Patients in Chhattisgarh
by: Sanjana Bhagat, et al.
Published: (2013-02-01)

Beta-globin gene cluster haplotypes in Venezuelan sickle cell patients from the State of Aragua
by: Nancy Moreno, et al.
Published: (2002-01-01)

Influence of ?S-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia
by: Marília Rocha Laurentino, et al.
Published: (2014-04-01)

Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease.
by: Laura M Raffield, et al.
Published: (2018-03-01)

Improved SARS-CoV-2 Spike Glycoproteins for Pseudotyping Lentiviral Vectors
by: Paul G. Ayoub, et al.
Published: (2021-11-01)

Presence of atypical beta globin (HBB) gene cluster haplotypes in sickle cell anemia patients of India
by: Sandor Rudy L. Nongbri, et al.

Alpha‐globin gene triplication and its effect in beta‐thalassemia carrier, sickle cell trait, and healthy individual
by: Mohammad Hamid, et al.
Published: (2021-08-01)

Promoter region sequence differences in the A and G gamma globin genes of Brazilian sickle cell anemia patients
by: C.G. Barbosa, et al.
Published: (2010-08-01)

Comment on "Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia"
by: Lidiane de Souza Torres
Published: (2014-04-01)

Amelioration of murine sickle cell disease by nonablative conditioning and Î³-globin gene-corrected bone marrow cells
by: Tamara I Pestina, et al.
Published: (2015-01-01)

The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgene.
by: Annarita Miccio, et al.
Published: (2011-01-01)

Haplotype of the βS-globin cluster in patients with sickle cell anemia at a University Hospital in the Triangulo Mineiro, Minas Gerais
by: Alexandra Silva Leal, et al.
Published: (2015-04-01)

Characterization of whole blood gene expression profiles as a sequel to globin mRNA reduction in patients with sickle cell disease.
by: Nalini Raghavachari, et al.
Published: (2009-01-01)

Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice
by: Adam C. Wilkinson, et al.
Published: (2021-01-01)

Haplotypes βs-globin and its clinical-haematological correlation in patients with sickle-cell anemia in Triângulo Mineiro, Minas Gerais, Brazil
by: Alexandra S. Leal, et al.

Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01)

Production of lentiviral vectors
by: Otto-Wilhelm Merten, et al.
Published: (2016-01-01)

Advances of Lentiviral Vectors
by: Fanrong MENG, et al.
Published: (2014-12-01)

Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
by: Maria Dahl, et al.
Published: (2021-03-01)

Renal dysfunction in patients with sickle cell anemia or sickle cell trait
by: R. Sesso, et al.
Published: (1998-10-01)